Access Power & Co Inc (ACCR)

[THE_BAMFACTSTER!!]

$$$ ACCR $$$ NO WORRIES!! MONEY HAS BEEN MADE HERE BY SMART ACCR INVESTORS.

ITS NOT A CONCERN WHAT THE PRINCIPAL DOES OR DOESNT DO.

ONLY THING THAT MATTERS IS MAKING DA MONEY!! OOP$ !! ROTFLMMFAOATWTTB

BBBBBBAM!!! FFFFFACT!!!

[Werbe]

Dont tell peeps UNS means grey market or expert market when others trade outside of grey/expert with UNS label.

[Zorax]

Um, grey/expert ARE only available as UNS. Pink current is meaningless in this regard.
Pink current has nothing to do with financial records but everything to do with paying the fees for otcm 'listing'. It's all advertising for the scam and otcm.

[Zorax]

Not new. Just the years requirement is all.

The last attorney bailed on xanaxu, probably because he stiffed him.

[Werbe]

I wonder if OTCM is rolling out a new way for attorneys to submit their letters? That agreement really forces a lot of info out, which is always the best way to light up these dark rooms.

Exhibit B To: Attorneys Providing Letters with Respect to Current Information for Companies Designated Caveat Emptor As a matter of policy, OTC Markets Group designates certain securities as 'Caveat Emptor' and places a skull and crossbones icon next to the stock symbol to inform investors that there may be reason to exercise additional care and perform thorough due diligence before making an investment decision in that security. The Caveat Emptor designation may be assigned when OTC Markets becomes aware of stock promotion, regulatory suspension, an investigation of fraud or other public interest concern. In addition to the requirements set forth in Exhibit A, if the issuer or its securities have been designated Caveat Emptor, counsel’s letter must also include the following: 16. The letter must identify any and all of the following individuals: A. Executive officer, director, general partner and other control person of the Issuer; B. Promoter, finder, consultant or any other advisor of the Issuer that assisted, prepared or provided information with respect to the Issuer’s disclosure or who received securities as consideration for services rendered to the Issuer; and C. Any individual beneficially owning 5% of shares or greater. For all individuals listed above, include all of the following information: i. full name; ii. business address (if available); iii. the number and class of the Issuer’s securities beneficially owned, including (a) the date(s) any class of the Issuer’s securities were issued to the individual (b) whether or not the certificates or other document that evidences the securities contains a legend stating that the securities have not been registered under the Securities Act and setting forth or referring to restrictions on transferability and sale of the securities and (c) a complete description of the consideration received by the Issuer in connection with each issuance of shares to such person, including, without limitation, the nature of any services performed for or on behalf of the Issuer; For purposes of this letter, the term “control person” includes (i) any person controlling, under common control with, or controlled by, the Issuer or (ii) any person who obtained securities of the Issuer in connection with a negotiation with the Issuer within the three-year period prior to the date of the opinion (iii) any person owning 5% or more of the company’s stock. With respect to any of the Issuer’s control persons that is an entity and any parent entity of any control person, the opinion must provide the information described in section C of item 16 for each control person of such entity or parent entity. 17. The letter must state that counsel has made specific inquiry of each of the persons listed in item 16 above, persons engaged in promotional activities regarding the Issuer, and persons owning more than five percent (5%) of the Securities (collectively, the “Insiders”), and based upon such inquiries and other information available to counsel, any sales of the Securities by Insiders within the twelve-month period prior to the opinion have been made in compliance with Rule 144, including, without limitation, any required filings of Form 144, and nothing has come to the attention of counsel indicating that any of the Insiders is in possession of any material non-public information regarding the Issuer or the Securities that would prohibit any of them from buying or selling the Securities under Rules 10b-5 or 10b5-1 under the Exchange Act.

[Werbe]

UNS quotes and being on grey/expert market are two different things. A ticker can be pink current and be UNS.

[mick]

pg. 4 --- https://www.otcmarkets.com/otcapi/company/financial-report/369398/content

[mick]

#3 440 East 400 South | Suite 200
Salt Lake City, UT 84111
Counsel confirmed that the transfer agent is registered with the SEC via the official SEC
website and its EDGAR system at http://www.sec.gov/edgar/searchedgar/webusers.htm. Counsel
has met with management and a majority of the Directors of the Issuer, reviewed the information
that has been published by the Issuer through the OTC Disclosure and News Service, and discussed
the information with management and a majority of the directors of the Issuer. Specifically,
Counsel has met with Mr. Fuqiang Li (CEO), and Mr. Meihua Xu, who represents the majority of
the Board of Directors. After inquiry of management and the directors of the Issuer, Counsel
represents that to the best knowledge of Counsel, the Issuer of the Securities, any 5% holder, and
Counsel himself are not currently under investigation by any federal or state regulatory authority
for any violation of federal or states securities laws.
Counsel has reviewed previous filings and determined the Issuer does currently meet the
definition of a shell in accordance with the definition of a “shell company” as stated in Rules 405
of the Securities Act of 1933 and 12b-2 of the Exchange Act of 1934.
No person other than OTC Markets Group is entitled to rely on this letter, but OTC Markets
Group has full and complete permission and rights to publish this letter through the OTC
Disclosure and News Service for viewing by the public and regulators.
This opinion does not include any assumption or expression regarding compliance with
any state security law.
Yours Truly,
________________________
Martin G. Prego, Esq.
FL Bar No. 1022152
Email: [e-mail]

[mick]

#2 --- Annual Report for the Period Ending December 31, 2022, pursuant to Rule 15c2-11 which
includes:
a. The Issuer’s History;
b. Addressees of Principal Executives;
c. Security Information;
d. Issuance History;
e. Description of the Issuer’s Business, Product and Services;
f. Description of the Issuer’s Facilities;
g. Officers, Directors, and Control Persons;
h. Third Party Providers;
i. Financial Statements; and
j. Issuer’s Certification.
Counsel has relied on information obtained from public officials, officers of the Issuer and
other sources in the rendering of this opinion letter and believes that all such sources are reliable.
Counsel has examined such corporate records and documents and has asked such questions of law
as was considered necessary or appropriate for the purpose of writing this letter. Counsel has
reviewed and relied on information from the Secretary of State of Florida and information obtained
from the Company's officers, directors, and agents. Counsel has personally met with and discussed
the above documentation with Mr. Fuqiang Li (CEO), and Mr. Meihua Xu, who represents the
majority of the Board of Directors. In the event that the facts and information in all such documents
are determined not to be true, this opinion shall be null and void.
There has been no information concerning the Issuer and the Securities that are publicly
available through the OTC Disclosure and News Service, other than information which has been
published to www.otcmarkets.com and the Quarterly Report which is the subject of this letter. In
issuing this letter, Counsel represents that the information referred to herein:
(i) Constitutes "adequate current public information" concerning the Securities and the
Issuer and "is available" within the meaning of Rule 144(c)(2) under the Securities Act;
(ii) Includes all of the information that a broker-dealer would be required to obtain from
the Issuer to publish a quotation for the securities under Rule 15c2-11 under the Securities
Exchange Act of 1934;
(iii) Complies as to form with the OTC Markets Group's Guidelines for Providing
Adequate Current Information, which are located on the internet at www.otcmarkets.com, and;
(iv) Will be submitted for posting through the OTC Disclosure and News Service.
The financial information reflected in the disclosure statement was not audited. The
financial information was compiled by Caren Currier as a consultant to the Issuer.
The Issuer's transfer agent is:
Standard Registrar & Transfer Co., Inc.
[phone]
Doc ID: dc0b486

[mick]

5-09-2023 $accr --- May 9, 2023.
ELECTRONIC SUBMISSION VIA E-MAIL
OTC Markets Group, Inc.
300 Vesey Street, 12th Floor
New York, NY 10282
RE: Legal Opinion, Adequate Current Information and Disclosure Filing by AccessPower & Co., Inc. (“ACCR”) Annual Report for the Period Ending December 31,
2022, and related disclosures.
Dear Sirs:
I have been retained as Counsel by Access-Power & Co., Inc., a corporation organized and
existing under the laws of the State of Florida (the "Issuer" or “ACCR”) solely for the purpose of
reviewing the current information supplied by the Issuer to OTC Markets Group, Inc. ("OTC
Markets Group"). The Issuer has requested that I render a sufficiency of adequate information
opinion (the "Opinion") in connection with the filing by the Issuer of its Annual Report for the
Period Ending December 31, 2022 (published 3/23/2023) and related disclosures (the "Report(s)")
pursuant to the OTC Markets Group, Inc. Pink Basic Disclosure Guidelines, Rule 15c2-11(a)(5)
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 144(c)(2) of
the Securities Act of 1933, as amended (the "Securities Act"). OTC Markets Group is entitled to
rely on this letter in determining whether the Issuer has made adequate current information
publicly available within the meaning of Rule 144(c)(2) under the Securities Act of 1933.

Counsel is a U.S. citizen and resident and is authorized to practice law in the State of
Florida and the Federal Courts of the United States. Counsel is also permitted to practice before
the U.S. Securities and Exchange Commission (SEC). Counsel is not currently, nor has in the past
five years, been the subject of an investigation, hearing, or proceeding by the SEC, the U.S
Commodity Futures Trading Commission (CFTC), the Financial Industry Regulatory Authority
(FINRA), or any other federal, state, or foreign regulatory agency. Counsel is not currently, nor
has been in the past five years, suspended or barred from practicing in any state or jurisdiction,
and has not been charged in a civil or criminal case. Furthermore, Counsel does not currently
beneficially own, owned in the past, or has any agreement to receive in the future any shares of
the Issuer’s securities.
Counsel has reviewed the following documents and related information posted at
www.otcmarkets.com and publicly available through the OTC disclosures and News Service in
connection with the preparation of this letter, which is believed to be reliable:

[mick]

FILINGS AND DISCLOSURE
OTC Disclosure & News
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
05/09/2023 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 12/31/2022 A
05/09/2023 Supplemental Information - ATTORNEY LETTER AGREEMENT SIGNED BY OTC AND ATTORNEY 12/31/2022 A
05/06/2023 Supplemental Information - ATTORNEY LETTER AGREEMENT 09/30/2022 A

[mick]

interesting ????? ah new , 05/09/2023 Limited Information IconACCR Supplemental Information ATTORNEY LETTER AGREEMENT SIGNED BY OTC AND ATTORNEY 12/31/2022

[Zorax]

new filings 5/6 for what it's worth theyre trying but sec doesnt want ppl like you and me to make money anymore

Actually has nothing to do with the SEC discouraging people to trade. Has everything to do with the fact that a-c-cr was never registered with the SEC, never a SEC filer and sending in technically illegal SEC letters to otcm which is frowned on by the SEC is meaningless. And for advertising purposes only. As with 8K's which are never used properly in the otcm any more.

otcm does not vet a single submission, it's in their disclaimers and the only reason they mention 'filing' at all is for the private owner of otcm to attempt to look legit and look like a exchange which he is not, and creates nothing tiers just to up the fees. It's the fees that keep a-c-c-r showing up on otcm, not the phony financials. A otcm requirement is empty hogwash.

[thereis]

new filings 5/6 for what it's worth theyre trying but sec doesnt want ppl like you and me to make money anymore

[mick]

well said Z

[Zorax]

Basically a-c-cr is Grey Market, although otcm is working hard to distance itself from the grey market labeling. I think it's been this way for years.

Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.

[Zorax]

A-cc-cr absolutely is a shell. It fits the SEC and Finra description to a tee. No income, no product, no legit financials, not allowed to use stock sales as income, no product in any market anywhere, permanent startup mode. The ex principal tried to claim it wasn't a shell early on.

He got caught and likely received a letter from the SEC and told 'don't do that'.

Just because a mentally handicapped ex owner said it wasn't a shell, doesn't make it true.

And corp rep attorneys have to file that letter every year.

[mick]

$ACCR ????? bid 0.0009 - ask 0.005's , i don't thinkzzz will see $0.005's again cyber man

sing sing

[mick]

laughing @ shareholders cyber man / attorney failed

[mick]

$ACCR ????? bid 0.0009 - ask 0.005's ,

[mick]

what did lawyer lie about ????? / https://www.otcmarkets.com/stock/ACCR/disclosure

FILINGS AND DISCLOSURE
OTC Disclosure & News
ActiveInactiveAll
The company has not provided financial reports or other disclosures to OTC Markets Group.

CyberCall™ nothing but b.s. now almost bankrupt/ soon no bid, CyberCall™

I received this update on my Clones by Drones patent application...here is another letter received TODAY from my PATENT ATTORNEY.

"... Please note that this is an estimate, and the response can arrive sooner or later than the time provided. Once we have received and reviewed it, we will reach out to let you know how to proceed...

Please see the attached First Office Action Prediction from the USPTO for your records. The attorney assigned to your application is patent prosecution manager XXXX XXXX who has plenty of experience in the patent field.

If you have any questions, please don’t hesitate to contact us. Have a great rest of your day!"
Bearish
BEARISH

[mick]

looks like OTC PINKS busted you., nothing but dis / 07-21-2021
SEC Filings
FORM TYPE RECEIVED PERIOD END DATE REPORT
4/A 07/20/2021 01/01/1999 PDFRTFHTMLXLS
4/A 07/20/2021 07/20/2021 PDFRTFHTMLXLS
15-12G 06/30/2021 PDFRTFHTMLXLS
4 05/19/2021 04/14/2021 PDFRTFHTMLXLS
4/A 05/19/2021 04/12/2021 PDFRTFHTMLXLS
4 05/10/2021 04/04/2021 PDFRTFHTMLXLS
4/A 04/29/2021 03/19/2021 PDFRTFHTMLXLS
4/A 04/09/2021 03/19/2021 PDFRTFHTMLXLS
4 03/22/2021 03/19/2021 PDFRTFHTMLXLS
8-K 03/12/2021 12/31/2020 PDFRTFHTML

CyberCall™ nothing but b.s. now almost bankrupt/ soon no bid, CyberCall™

I received this update on my Clones by Drones patent application...here is another letter received TODAY from my PATENT ATTORNEY.

"... Please note that this is an estimate, and the response can arrive sooner or later than the time provided. Once we have received and reviewed it, we will reach out to let you know how to proceed...

Please see the attached First Office Action Prediction from the USPTO for your records. The attorney assigned to your application is patent prosecution manager XXXX XXXX who has plenty of experience in the patent field.

If you have any questions, please don’t hesitate to contact us. Have a great rest of your day!"
Bearish
BEARISH

[mick]

these were dare this morning now gone / $ACCR / FILINGS AND DISCLOSURE / 05-05-2023, 04-21-2023, 03-23-2023
OTC Disclosure & News
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
05/06/2023 Supplemental Information - ATTORNEY LETTER AGREEMENT 09/30/2022 A
04/21/2023 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 12/31/2022 A
03/23/2023 Annual Report - Annual Report 12/31/2022 A
11/04/2022 Quarterly Report - q3,2022 09/30/2022 A

[mick]

otc pinks removed what was there current filings

FILINGS AND DISCLOSURE
OTC Disclosure & News
ActiveInactiveAll
The company has not provided financial reports or other disclosures to OTC Markets Group.

[mick]

what does this mean ????? 05/06/2023 Supplemental Information - ATTORNEY LETTER AGREEMENT 09/30/2022 A

the otc pinks no accept $ACCR letter ?????
04/21/2023 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 12/31/2022 A

[mick]

excerpt; $ACCR yes - shell, no change, no a Change in Control1 of the company has occurred,

https://www.otcmarkets.com/otcapi/company/financial-report/362480/content

Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the
dates of the name changes.
Originally formed as Access Power, Inc. on October 10, 1996, in the state of Florida, changed its name to Access-Power
& Co., Inc. during September, 2018

Florida – In good Standing
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently
anticipated or that occurred within the past 12 months:
None
The address(es) of the issuer’s principal executive office:
As of the date of this report: 550 Highway 7, #316, Richmond Hill, ON, L4B3Z4, Canada

Publicly Quoted or Traded Securities:?
Trading symbol: ACCR
Exact title and class of securities
outstanding:
Common
CUSIP: 00431N108
Par or stated value: .001
Total shares authorized: 500,000,000 as of date: December 31, 2022
Total shares outstanding: 301,500,000 as of date: December 31, 2022
Number of shares in the Public Float2
: 98,244,146 as of date: December 31, 2022
Total number of shareholders of record: 568 as of date: December 31, 2022
Other classes of authorized or outstanding equity securities:
NONE

B. Promissory and Convertible Notes
Indicate by check mark whether there are any outstanding promissory, convertible notes, convertible debentures, or any
other debt instruments that may be converted into a class of the issuer’s equity securities:
No: X Yes: ? (If yes, you must complete the table below)

6) Officers, Directors, and Control Persons
Name of
Officer/Director or
Control Person
Affiliation with
Company (e.g. Officer
Title /Director/Owner
of more than 5%)
Residential Address
(City / State Only)
Number of
shares owned
Share
type/class
Ownership
Percentage
of Class
Outstanding
Note
Meihua Xu Chairman/President Ontario, Canada 141,550,000 Common 53.35% Acquired in Private
Sale
Fuqiang Li CEO Ontario, Canada 0 Common 0
Jing Zhang Secretary Ontario, Canada 0 Common 0
Patrick Jensen Investor Grand Haven, MI 26,934,379 Common 8.93%
Fuqiang Li, CEO
Principal Financial Officer:
I, Meihua Xu certify that:
1. I have reviewed this Annual Disclosure Statement of Access-Power & Co, Inc for the year ended
December 31, 2022.
2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this disclosure
statement; and
3. Based on my knowledge, the financial statements, and other financial information included or
incorporated by reference in this disclosure statement, fairly present in all material respects the financial
condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure
statement.
March 24, 2023 /s/ Meihua Xu
Meihua Xu, Chairman/President


https://www.otcmarkets.com/otcapi/company/financial-report/362480/content

[mick]

$ACCR / FILINGS AND DISCLOSURE / 05-05-2023, 04-21-2023, 03-23-2023
OTC Disclosure & News
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
05/06/2023 Supplemental Information - ATTORNEY LETTER AGREEMENT 09/30/2022 A
04/21/2023 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 12/31/2022 A
03/23/2023 Annual Report - Annual Report 12/31/2022 A
11/04/2022 Quarterly Report - q3,2022 09/30/2022 A

[mick]

$ACCR /\ RELEASE DATE SYMBOL REPORT TYPE TITLE PERIOD END DATE
05/06/2023 Limited Information IconACCR Supplemental Information ATTORNEY LETTER AGREEMENT 09/30/2022

[Zorax]

Otc is worthless
A-c-cr is worthless.
Includng the scammer principal.

A-c-c-r principal scammer sold to a bigger scammer.
It is what it is.

[mick]

yes still in bear mode since 22 mos now

[MattyTrader]

Otc is worthless

[mick]

CyberCall™ nothing but b.s. now almost bankrupt/ soon no bid, CyberCall™

I received this update on my Clones by Drones patent application...here is another letter received TODAY from my PATENT ATTORNEY.

"... Please note that this is an estimate, and the response can arrive sooner or later than the time provided. Once we have received and reviewed it, we will reach out to let you know how to proceed...

Please see the attached First Office Action Prediction from the USPTO for your records. The attorney assigned to your application is patent prosecution manager XXXX XXXX who has plenty of experience in the patent field.

If you have any questions, please don’t hesitate to contact us. Have a great rest of your day!"

[mick]

yes now almost worthless

[mick]

worry do not be happy, today is dunn in day $ACCR, bu ????? on heels of no bid.

re;
$$ ACCR $$$ NO WORRIES!! MONEY HAS BEEN MADE HERE BY SMART ACCR INVESTORS.

ITS NOT A CONCERN WHAT THE PRINCIPAL DOES OR DOESNT DO.

ONLY THING THAT MATTERS IS MAKING DA MONEY!! OOP$ !! ROTFLMMFAOATWTTB

BBBBBBAM!!! FFFFFACT!!!

[mick]

8-22-2023 now worthless --- 05-04-2023 you are worthless now --- no patent application., no good

re;
USPTO. I’m still waiting to hear about my Clones by Drones patent application. My patent involves “line of sight” technology. TRUST is everything in life. I’m so happy these days.

[MattyTrader]

Totally ridiculous. OTCM putting everyone’s money to sleep

[thereis]

current report and AL submitted, yet limited? otc hatin'

[mick]

ACCR
Access Power & Co Inc (PK)
0.0016
-0.0014 (-46.67%)
Volume: 500
Day Range: 0.0016 - 0.0016
Last Trade Time: 9:31:51 AM EDT

[mick]

ACCR
Access Power & Co Inc (PK)
0.003
0.00 (0.00%)
Volume:

[price_and_volume]

Absolutely nothing happening here. Consider yourself updated.

Would be nice to get an update

A woefully mis-managed shell that had potential in the right hands... but just didn't fall into the right hands.

Oh well.

[MattyTrader]

Would be nice to get an update

[mick]

drones ????? $ACCR

[MattyTrader]

SS great here… would move nicely if they ever get anything done

[mick]

floundering ACCR
Access Power & Co Inc (PK)
0.002
0.00 (0.00%)
Volume:

[m$teamworkotc]

DID THAT CON ARTIST POS XU RETURN YOUR CALLS ON YOUR OFFER?

[mick]

CC good after noon ACCR 0.0050 +0.0032 +177.78% USD 10:50AM EDT 18,600

[shajandr]

I am curious as to what illness will befall his wife this time - just Jensen trying to get sympathy

Spot on!

Select one or more of the following bullshit maladies:

1. Eczema
2. Snake bite
3. Malaria
4. Leishmaniasis
5. Marburg virus
6. Dandruff
7. Ebola
8. Fly bites
9. Alopecia
10. IBS/Crohn's
11. Cheyne-Stokes respiration
12.Legg-Calvé-Perthes disease
13. Flea-bitten kidney
14. Osteomalacia imperfecta
15. Gout
16. Hammertoe
17. Seborrhea
18. Dry eyes
19. Shingles
20. Bradycardia
21. Gall stones
22. Amenorrhea
23. Dropsy
24. Bad breath
25. Kidney stones
26. Lockjaw
27. African sleeping sickness
28. Flatulence
29. Histoplasmosis
30. Pleurisy
31. Black lung
32. Nitrogen narcosis
33. Decompression sickness ("the bends")
34. Migraine
35. Toe fungus
36. General pariesis
37. Parkinsonism
38. Dissecting aortic aneurysm
39. Appendicitis
40. Avian influenza
41. Osteogenic sarcoma
42. Teratoma
43. Osteoarthritis
44. Strep throat
45. CONstipation
46. Gastric reflux
47. Bee sting allergic anaphylaxis
48. Glioblastoma multiformans
49. Cardiac tamponade
50. EIghtball eyes
51. Petichial hemorrhage of eyes
52. Varicose veins
53. Gallbladder inflammation
54. Hemorrhoids
55. Reyes; syndrome
56. Filiarisis
57. Trypanosomiasis
58. Cerebrovascular infact
59. Pulmonary fibrosis
60. Mesothelioma
61. Grave's disease
62. Glaucoma
63. Crabs
64. Wilson's disease
65. Hemochromatosis
66. Retinobalstoma
67. InCONtinence
68. Schistosomiasis
69. Scoliosis
70. Jones fracture
71. ALS (Lou Gehrig's disease)
72. Pick disease
73. Lewy Body disease
74. Tourette's syndrome
75. Huntington's chorea
76. COPD
77. Polio
78. Emphysema
79. Athlete's foot
80. Kaposi's sarcoma
81. Polycystic kidney
82. Tularemia
83. Giardiasis
84. Tapeworm
85. Radiation sickness
86. Traumatic brain injury
87. Nystagmus
88. Smallpox
89. Aplastic anemia
90. Myelodystrophy
91. Multiple sclerosis
92. Chronic lymphocytic leukemia (CLL)
93. Melanoma
94. Cirrhosis of the liver/hepatic cirrhosis
95. Hemophilia
96. Addison's disease
97. Cushing syndrome
98. Clubfoot
99. Leprosy/Hansen's disease
100. Asystole.

[mick]

$ACCR

[I-Glow]

Total dollar volume was only about $102 - hardly a great deal of interest.

But then you were posting about how the goofball Jensen's car selling business model and oddly you are excited about every idea.

Remember when some Prince was going to provide funding - then the new CEO that never happened - and selling the shell to a serial scammer and that screwed over investors. There are dozens of examples that provide evidence of Jensen being mentally unbalanced.

Jensen couldn't get a trademark approved for Clones by Drones - so there isn't any chance of getting a patent for Clones by Drones - it shows how delusional Jensen is and always has been.

I am curious as to what illness will befall his wife this time - just Jensen trying to get sympathy.

Time to get off of Jensen's leg.

IG

[mick]

interesting CC / ACCR 0.0050 +0.0032 +177.78% USD 10:50AM EDT 18,600

someone likes $ACCR